05/17/2024
7:27 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
8:33 AM | Autolus Therapeutics (Filer)
| Form NT 10-Q | |
05/13/2024
6:23 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
6:06 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:10 PM | Autolus Therapeutics (Subject)
Kellnerova Renata (Filed by)
| Form SC 13D/A | |
03/21/2024
3:21 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:21 PM | Autolus Therapeutics (Filer)
| Form 8-K/A | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
03/14/2024
11:32 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
4:28 PM | Autolus Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/14/2024
1:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Autolus Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:37 AM | Autolus Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:41 PM | Autolus Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
| Form SC 13G/A | |
02/09/2024
4:15 PM | Autolus Therapeutics (Filer)
| Form 424B5 | |
02/08/2024
3:17 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
9:00 PM | Autolus Therapeutics (Filer)
| Form S-3ASR | |
02/08/2024
5:06 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:10 PM | Autolus Therapeutics (Subject)
Tetragon Financial Management LP (Filed by)
| Form SC 13G/A | |
01/26/2024
12:02 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
2:12 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:24 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
7:31 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
6:07 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
8:18 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:26 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/03/2023
3:32 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023
3:07 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023
4:00 PM | Autolus Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
07/06/2023
3:29 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
7:18 AM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
7:11 AM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
